AstraZeneca There are more than half points left on this Tuesday. The company’s title is hurt by the news that the British regulator may prohibit the use of its vaccine even in persons under 30 years of age.
According to various media in the country, British bodies remain concerned about cases of “rare clots”, which have so far left seven out of the more than 18 million people who have been vaccinated there with AstraZeneca.
This Monday, Channel 4 News reported that the regulator was testing this possibility, and it may take a final decision this Tuesday. “Two sources have commented for the event that although the data are inconclusive, The possibility of offering youth under 30, a different vaccine is growing strongly ”.
Both sources have also led the channel to believe that the intention of the Boris Johnson government is to continue to support the Oxford and AstraZeneca vaccines, so that any possible extent of its use could harm public confidence.
In Spain, it should be remembered that The Ministry of Health approved the use of the AstraZeneca vaccine in more than 65 essential workers on 30 March, Thus creating adjacent Janssen vaccines for populations over 66 years old. In addition, it is anticipated that the department will propose the use of the British vaccine “soon” even in people over 65 years of age.
“Wannabe troublemaker. Pop culture fanatic. Zombie nerd. Lifelong bacon advocate. Alcohol enthusiast. Tv junkie.”